OpenLegislation

Paragraph 31 Format of the abstract of the final study reportF1

The abstract of the final study report for a non-interventional post-authorisation safety studies must be submitted in the following format—

(a)

title, with subtitles including date of the abstract and name and affiliation of main author;

(b)

keywords (not more than five keywords indicating the main study characteristics);

(c)

rationale and background;

(d)

research question and objectives;

(e)

study design;

(f)

setting;

(g)

subjects and study size, including dropouts;

(h)

variables and data sources;

(i)

results;

(j)

discussion (including, where relevant, an evaluation of the impact of study results on the risk–benefit balance of the product);

(k)

name of holder; and

(l)

names and affiliations of principal investigators.

Annotations

Textual amendments

F1

Sch. 12A inserted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 6 (as amended by S.I. 2019/1385, reg. 1, Sch. 1 para. 9 and S.I. 2020/1488, reg. 1, Sch. 2 para. 192); 2020 c. 1, Sch. 5 para. 1(1)